Drotrecogin alfa (activated): is there room for improvement?
Kath
K
Cunningham
Zorica
Z
Jankovic
D018806:APACHE; D000368:Aged; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D016208:Databases, Factual; D004739:England; D017052:Hospital Mortality; D006801:Humans; D008875:Middle Aged; D009102:Multiple Organ Failure / Q000401:mortality; D011183:Postoperative Complications; D011486:Protein C / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use; D018805:Sepsis / Q000188:drug therapy; D013997:Time Factors; D016896:Treatment Outcome
D000890:Anti-Infective Agents; D011486:Protein C; D011994:Recombinant Proteins; C421124:drotrecogin alfa activated